Sunshine Biopharma Inc. (SBFMW) stock
SBFMWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFM
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.03+0.00 (+2.00%)
Close on Oct 30, 2026Market cap $11.36MP/E –Yield –
Sunshine Biopharma total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Sunshine Biopharma's total debt was $0 at Dec 31, 2022. For fiscal 2022 it was $0, down 100.0% from the year before. The highest annual figure on record is $1.90M in fiscal 2021.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | -100.0% |
| FY2021 | Dec 31, 2021 | $1.90M | +100.2% |
| FY2020 | Dec 31, 2020 | $949.01K | – |
| FY2019 | Dec 31, 2019 | $0 | -100.0% |
| FY2018 | Dec 31, 2018 | $289.85K | +263.6% |
| FY2017 | Dec 31, 2017 | $79.71K | – |
| FY2016 | Dec 31, 2016 | $0 | -100.0% |
| FY2015 | Dec 31, 2015 | $102.14K | – |
| FY2014 | Dec 31, 2014 | $0 | – |
| FY2013 | Dec 31, 2013 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $0 | -100.0% |
| Q3 FY2022 | Sep 30, 2022 | $0 | -100.0% |
| Q2 FY2022 | Jun 30, 2022 | $0 | -100.0% |
| Q1 FY2022 | Mar 31, 2022 | $0 | -100.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.90M | +100.2% |
| Q3 FY2021 | Sep 30, 2021 | $3.20M | +796.2% |
| Q2 FY2021 | Jun 30, 2021 | $2.05M | +3148.6% |
| Q1 FY2021 | Mar 31, 2021 | $2.08M | – |
| Q4 FY2020 | Dec 31, 2020 | $949.01K | +227.4% |
| Q3 FY2020 | Sep 30, 2020 | $357.55K | – |
| Q2 FY2020 | Jun 30, 2020 | $63.23K | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q4 FY2018 | Dec 31, 2018 | $289.85K | +263.6% |
| Q3 FY2018 | Sep 30, 2018 | $0 | – |
| Q2 FY2018 | Jun 30, 2018 | $0 | – |
| Q1 FY2018 | Mar 31, 2018 | $0 | – |
| Q4 FY2017 | Dec 31, 2017 | $79.71K | – |
| Q4 FY2016 | Dec 31, 2016 | $0 | – |